Known risk factors for breast cancer do not account for a significant proportion of the overall incidence. Reproductive factors and endogenous hormones are thought to be responsible for a large component of risk. An environmental contribution has been sought in the past to explain the international trends in breast cancer rates and changes in risk among migrating populations. Recently, environmental research has turned to investigation of exogenous chemical exposures, including environmental contamination, as potential risk factors that may arise from the hormonal activity or from the carcinogenicity of many of these chemicals. Several reports since 1991 suggest that organochlorines may be a risk factor for breast cancer. The data are strongest for DDT. For PCBs, the results to date have been equivocal if not entirely negative. However, different groups of polychlorinated biphenyl (PCB) congeners are known to provoke biological responses that are structure specific. A wide divergence of estrogenic response, cytochrome P450 activity, and biological half-life exists within these groups of PCB congeners. Therefore, understanding breast-cancer risk from PCB exposure requires attention to congener structures in complex mixtures and to temporal changes in exposure. Investigation of environmental contributions to breast cancer risk offers the potential for understanding more about the etiology of this complex disease and may also provide opportunities for prevention of the most common cancer among women in the United States. -Environ Health Perspect 103(Suppl 7): 141-145 (1995) 
Introduction
Reproductive history and hormonal factors are widely accepted as major risk factors for breast cancer. Environmental exposures may also be important in breast cancer etiology, as indicated by international variations in incidence and studies of migrant populations. However, research on specific environmental chemicals that may contribute to (Table 1) . A fifth study reported no statistically significant differences in DDE between cases and controls, although the results for the African-American and Caucasian subgroups were consistent with previous studies. The relative risks reported in these studies are in the range of 2 to 10, so that they rank among the higher risks observed for breast cancer in the epidemiologic literature. The evidence is strongest in supporting a relationship between DDT and breast cancer. An earlier study while not disproving this hypothesis failed to find an association (2 (3) .
Similar risks for breast cancer were found among Finnish women with elevated levels of P-hexachlorocyclohexane, a lindane-derived residue (5) . A recent report from Canada found significantly higher levels of DDE in estrogen receptorpositive breast cancer cases compared with controls (6) .
A fifth study used blood serum that had been gathered during the late 1960s in a California health maintenance organization 1 to 20 years before cancer diagnosis (7) . Levels of serum organochlorines were compared among 150 breast cancer cases (onethird each Caucasian, African-American, and Asian) and an equal number of controls from the same cohort. Although there were no differences in DDE and PCB levels when the three groups were considered in the aggregate, serum DDE levels appeared to be as important a risk factor among African-American and Caucasian women (but not among Asians) as in previous studies ( Table 2) .
In summary, the current status of the case-control studies relating breast cancer risk to organochlorine exposure suggests a relationship with DDT exposure (Tables 1,  2 ). The magnitude of the estimated risks from the recently cited studies is similar to the risks that have been estimated using data from experimental animals (8,9).
PCBs and Breast Cancer Risk
The evidence for risk from exposure to PCBs and other organochlorines is equivocal, but there are interesting trends in the available data for PCBs that merit further study. Since PCBs occur as complex mixtures, their biological effects might be expected to represent an integrated response to the individual components of these mixtures. However, all but one of the cited reports have used total PCBs as the exposure measure. Total PCBs as found in humans can represent the sum of 10 to 40 PCB congeners, depending on the laboratory method and on an individual's exposure.
An alternative approach is to investigate the PCB exposures in a congener-specific fashion, which may reveal structure-activity relationships like those observed in experimental animals. A first important example is the potential for a range of estrogenic and antiestrogenic activity for congeners with specific chlorine substitution patterns (Figure 1)(10) . Second, persistence, or resistance to metabolism, is also stereospecific. A third inherent PCB property, the potential for inducing cytochrome P450 enzymes, also varies according to structure (Table 3) . Three possible structure-activity groups (I, II, III) can be established that categorize these properties.
Their currently recognized estrogenic response may be characterized as estrogenic, antiestrogenic, and neither (groups I-III; Figure 1 , Table 3 ). It is apparent that the estrogenic PCB congeners (group I) are characterized by a chlorine pattern that is also known to be more rapidly metabolized than the coplanar or typical persistent congeners (Table 3) (11) . Group I congeners have two adjacent nonsubstituted lateral carbon atoms on at least one of the biphenyl rings by definition, including one or two unsubstituted 4 or para positions. PCBs with this structure, including the Aroclor 1221 mixture that contains numerous congeners from this group, have estrogenic activity, as documented by their ability to increase uterine weight and cause precocious puberty (12) , to bind to the estrogen receptor (13) , and to enhance proliferation of MCF-7 breast tumor cells (14) .
Group II PCBs have 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-or dioxinlike properties that have been shown to be antiestrogenic. Their antiestrogenicity is thought to arise from interaction with the Ah receptor. This receptor best fits congeners that can achieve coplanar stereochemistry of the biphenyl rings (10) . The structural requirement for coplanarity is the absence of 2, 6, or ortho chlorines. The most active congeners are substituted at the 3,4 positions on both biphenyl rings. As a result, these non-ortho substituted congeners have no chlorines on the 2 (or the equivalent 6) positions, providing an avenue for metabolism at these adjacent unsubstituted carbon atoms, albeit not as facile as for group I. Therefore, the coplanar PCBs may be more persistent than group I and yet more readily metabolized than the very persistent congeners in group III. Also, some PCBs with a single ortho chlorine appear to retain some of the characteristics of group II. For example, the mono-ortho PCB 2,3',4,4',5,5'-hexaCB is approximately a 100-fold less active than the non-ortho analog 3,3',4,4',5-pentaCB (10) .
The antiestrogenic effects of the PCB congeners in group II could lead to protection against breast cancer and could counteract the estrogenic activity of other PCB congeners. TCDD administration to rats caused a decrease in normally occurring breast and uterine tumors and in chemically induced mammary tumors (15, 16) . TCDD and structural analogs including the coplanar PCBs are antiestrogenic in the MCF-7 breast cancer line (10) . Mixtures exhibit properties consistent with their multiple components. Thus, while the estrogenic PCB mixture Aroclor 1221 causes precocious puberty (12) , another mixture (Clophen A-50, which contains many antiestrogenic congeners) delays onset of puberty in female rats (17) . Similarly estrogenic organochlorines support implantation and pregnancy, while TCDD inhibits implantation (18) .
Group III congeners are highly substituted, persistent PCBs. Some of these congeners may have weak estrogenic activity (19) . Moreover, their extensive chlorination means that both 2 and 4 positions are substituted in many congeners and that there are few if any adjacent unsubstituted carbons. These configurations are not amenable to metabolism, and therefore these PCBs are very persistent in the body.
In addition to the diverse estrogenicity and metabolic rate of these three groups, the ability to induce cytochrome P450 (20) . From Table 3 , it can be seen that marked differences in persistence of PCB congener types also limit the period of time following exposure during which a biological effect could take place. Group I's estrogenic activity would be available for. only a few months before elimination was complete in humans. The antiestrogenic effects of the coplanar PCBs in group II may prevail longer than group I, but such activity may exist over a shorter time period than the effects of other, noncoplanar congeners in group III. From this line of reasoning, the risk for breast cancer from exposure to group II could be hypothesized to be lower in the short term (e.g., protective effect of antiestrogenic exposures) and higher in the long term (e.g., persistent exposures to a carcinogen and to an inducer of carcinogen-metabolizing enzymes). It has also been postulated that group II compounds are protective by facilitating metabolism of estradiol to a less genotoxic estrone, the 2-hydroxy isomer (21) . Group III, on the other hand, may affect cancer over the long term by influencing estradiol metabolism to the more toxic 16a-hydroxy isomer and by enhancing metabolism of carcinogens. In addition, some congeners in this category may also act as hormonal agonists (19) .
In summary, both the hormonal activity and the metabolic profile of persistent organochlorines must be taken into account in assessment of their long-term effects. The evidence to support this concept comes mainly from experimental data such as that cited above. Human data are limited. There is no evidence for an association of PCBs with breast cancer from the few reported mortality studies (22) .
However, the exposure measures in these reports relied only on duration of exposure, not on any personal or biological measures or on any information on PCB congeners. Also these studies were based on mortality, rather than incidence, data. Very limited data from studies of dioxin-exposed groups Volume 103, Supplement 7, October 1995 suggest that short-term exposures to TCDD may show a protective effect (e.g., in Seveso), while long-term exposures to TCDD and other organochlorines in manufacture show slightly elevated risk (Table  4) . Further studies, taking into account the complex qualitative nature of toxicity including the stereospecificity and toxicokinetics of organochlorines, should be undertaken to examine the health risks of such exposures.
Conclusions
Several mechanisms, not necessarily mutually exclusive, can be proposed to explain the association between organochlorine exposure and breast cancer risk. First, since they mimic estrogens in experimental studies, organochlorines may serve as cancer promoters in the same fashion as steroid hormones do. That is, estrogen promotes tumorigenesis in animal experiments, and epidemiologic evidence supports a similar mechanism in humans. In vitro experiments demonstrate the ability of estrogen and its synthetic analogs to cause proliferation of breast cancer cells in culture (14, 23 Gladen and Rogan (33) confirmed the negative impact of DDE on duration of lactation in a second group of women from Mexico. Finally, p,p'-DDE demonstrated antiandrogenic responses both in vitro and in vivo in the rat (34) , observations that underscore the importance of investigating a range of hormone function for environmental contaminants (35) .
